<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> includes the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> and reproductive function disturbances </plain></SENT>
<SENT sid="1" pm="."><plain>The aim was to show our diagnostic and therapeutic experiences </plain></SENT>
<SENT sid="2" pm="."><plain>62 women were included in study, 32 with primary antiphospholipd syndrome (PAPS), and 30 with <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> (SAPS) </plain></SENT>
<SENT sid="3" pm="."><plain>36 were pregnant and studied prospectively throughout pregnancy and six weeks after the delivery </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e>-<z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) was positive in 23 patients with PAPS (71.9%), and in 10 patients with SAPS (33.3%) </plain></SENT>
<SENT sid="5" pm="."><plain>In SAPS group anticardiolipin antibodies (aCL) was positive in 8 patients (26.6%) compared to PAPS group with 3 aCL positive patients (9.4%) </plain></SENT>
<SENT sid="6" pm="."><plain>Antibeta2glycoprotein1 (antibeta2GP1) was positive in 3 patients with PAPS </plain></SENT>
<SENT sid="7" pm="."><plain>Complications in previous pregnancies were in 25 cases (69.4%) <z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo>, in 7 cases (19.4%) <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> with <z:hpo ids='HP_0001511'>intrauterine growth restriction</z:hpo> (IUGR) in 3 patients </plain></SENT>
<SENT sid="8" pm="."><plain>In 4 cases the complication was fetal <z:hpo ids='HP_0011420'>death</z:hpo> in utero </plain></SENT>
<SENT sid="9" pm="."><plain>Average pregnancy lasted 37.06+/-0.707 weeks </plain></SENT>
<SENT sid="10" pm="."><plain>Therapy with low dose aspirin and low-molecular-weight <z:chebi fb="5" ids="28304">heparin</z:chebi> was successful in 97.2% </plain></SENT>
</text></document>